AI Tool Developed in the US Predicts Barrett’s Esophagus Recurrence After Endoscopic Therapy

Researchers in the United States have developed an artificial intelligence-based tool designed to predict the recurrence of Barrett’s esophagus (BE) following endoscopic eradication therapy (EET). BE is a condition that can lead to esophageal adenocarcinoma, a type of cancer. The AI model aims to assist medical professionals in identifying patients at higher risk for recurrence, potentially improving post-treatment surveillance strategies.

The predictive model uses advanced algorithms to analyze patient data and forecast the likelihood of BE returning after treatment. This development represents a significant step in utilizing technology to enhance disease management and monitoring. By providing individualized risk assessments, the tool may help healthcare providers make more informed decisions about follow-up care and interventions for patients who have undergone EET. Researchers continue to refine the model as part of ongoing efforts to improve outcomes for individuals affected by this precancerous condition.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

Author

GOAI